MA H4367

Requires all hospitals and birthing facilities to screen newborns for congenital cytomegalovirus (cCMV) using saliva or urine PCR tests within 21 days of birth and before discharge, with protocols to be adopted by January 1, 2028

Mandates a one-year pilot program to optimize testing, reporting, and medical care processes before universal screening begins in year two after passage

Establishes a public information program requiring healthcare providers to give expectant and new parents evidence-based written information about cCMV prevention at the first prenatal appointment

Makes cCMV screening a covered benefit under all health insurers, with the Commonwealth paying costs when no third-party payer exists; parents may opt out based on religious beliefs

Creates an advisory committee including medical specialists, parents of cCMV-affected children, and early intervention representatives to advise on screening standards and regulations